What Is Shandong Pharmaceutical Intermediate?
April 23, 2020. Customized in the middle of Shandong Pharmaceutical. The so -called Shandong pharmaceutical intermediate is actually some chemical raw materials or chemical products for drug synthesis process. This kind of chemical product does not require the production license of drugs. It can be produced in ordinary chemical plants. As long as it reaches some levels, it can be used for the synthesis of drugs.
There are more than 2,000 raw materials and intermediates that need to be matched with chemicals each year, with more than 2.5 million tons. After more than 30 years of development, the chemical raw materials and intermediates required for pharmaceutical production in my country are basically supported, and only a small part of the need to import. And because my country's resources are relatively rich and the price of raw materials is low, many intermediates have achieved a large export.
After the glory pharmaceutical intermediate industry industry in the late 1990s, the competition between the mature period of enterprises has reached the same force that the last force that is fighting at the end. Who can stick to it. And the temptation of other factors has continued to have new investors full of "gold rush" dreams entering the industry, but as the state demands that pharmaceutical companies conduct GMP certification and various overseas certification, the investment scale of the pharmaceutical industry has increased in geometric levels. The economic and social benefits of limited funds and energy have become the goal pursued by each pharmaceutical intermediate investor.
The impact of economic globalization process is the most far -reaching impact on my country's economy, that is, each manufacturer does not need to be large and complete. It should focus on the industry and fields they are good at. Materials and conditions can be completed by social collaboration. By forming a product chain, the cooperation parties can achieve a win -win situation. Under the influence of this concept, the pharmaceutical industry transferred the processing of some primary products, such as solvent recovery, to the collaborative enterprise to complete. Under the influence of this concept, the pharmaceutical industry transferred the processing of some primary products, such as solvent recovery, to the collaborative enterprise to complete. In the future, some products with certain pollution and danger are gradually transferred to chemical plants to produce, such as phenylene and chlorolate used in producing penicillin.
Because there is no production license for pharmaceutical products in the pharmaceutical intermediate industry, it is impossible to compete with the market with pharmaceutical companies. Therefore, the cooperation between the two parties has a certain complementarity.
